Results 21 to 30 of about 584,176 (310)

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review

open access: yesBMC Infectious Diseases, 2016
Background In many industrialized countries routine vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV-23) is recommended to prevent pneumococcal disease in the elderly. However, vaccine-induced immunity wanes after a few years, and
Cornelius Remschmidt   +4 more
doaj   +1 more source

Balancing Routine and Pandemic: The Synergy of India’s Universal Immunization Program and COVID-19 Vaccination Program

open access: yesVaccines, 2023
The COVID-19 pandemic posed substantial challenges to healthcare systems globally and severely disrupted essential health services, including routine immunization programs.
Pawan Kumar   +10 more
doaj   +1 more source

Efficient Immunization Strategies for Computer Networks and Populations

open access: yes, 2003
We present an effective immunization strategy for computer networks and populations with broad and, in particular, scale-free degree distributions. The proposed strategy, acquaintance immunization, calls for the immunization of random acquaintances of ...
Daniel ben-Avraham   +6 more
core   +1 more source

Using immunisation caregiver journey interviews to understand and optimise vaccination uptake: lessons from Sierra Leone

open access: yesBMJ Global Health, 2021
Quantitative and qualitative assessments have revealed diverse factors that influence the uptake of childhood immunisation services and shed light on reasons for vaccination delays and refusals. UNICEF and partner organisations developed the Immunisation
Dimitri Prybylski   +15 more
doaj   +1 more source

Effects of immunization in small-world epidemics [PDF]

open access: yes, 2001
The propagation of model epidemics on a small-world network under the action of immunization is studied. Although the connectivity in this kind of networks is rather uniform, a vaccination strategy focused on the best connected individuals yields a ...
Kuperman, Marcelo, Zanette, Damian H.
core   +1 more source

Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses

open access: yesDrug Delivery, 2018
Avian influenza virus infection is a serious public health threat and preventive vaccination is the most cost-effective public health intervention strategy.
Weiping Cao   +8 more
doaj   +1 more source

Is the impact of childhood influenza vaccination less than expected: a transmission modelling study

open access: yesBMC Infectious Diseases, 2017
Background To reduce the burden of severe influenza, most industrialized countries target specific risk-groups with influenza vaccines, e.g. the elderly or individuals with comorbidities.
Felix Weidemann   +5 more
doaj   +1 more source

Dispersion measures as immunization risk measures [PDF]

open access: yes, 2002
The quadratic and linear cash flow dispersion measures M2 and Ñ are two immunization risk measures designed to build immunized bond portfolios. This paper generalizes these two measures by showing that any dispersion measure is an immunization risk ...
Balbás, Alejandro   +2 more
core   +5 more sources

Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China

open access: yesInfectious Diseases of Poverty, 2019
Background Mother to child transmission of hepatitis B virus (HBV) remains the most common form of HBV infection in China. Prevention of HBV vertical transmission involves timely administration of the complete hepatitis B vaccine (HepB) series and ...
Hui Zheng   +9 more
doaj   +1 more source

Passive immunization against Histomonas meleagridis does not protect turkeys from an experimental infection [PDF]

open access: yes, 2009
Histomonosis or blackhead is a disease of gallinaceous birds, caused by the protozoan Histomonas meleagridis. As recent regulatory action has removed almost all drugs against this disease from the European market, the development of new prophylactics has
Bleyen, Nele   +3 more
core   +4 more sources

Home - About - Disclaimer - Privacy